Identifying depressive subtypes in a large cohort study: Results from the Netherlands Study of Depression and Anxiety (NESDA)

Journal of Clinical Psychiatry

Volumn 71, Issue 12, 2010, Pages 1582-1589

  Lamers, Femke ^a   De Jonge, Peter ^b,c   Nolen, Willem A ^b   Smit, Johannes H ^a   Zitman, Frans G ^d   Beekman, Aartjan T F ^a   Penninx, Brenda W J H ^a,b,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BODY MASS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; NETHERLANDS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; ADULT SURVIVORS OF CHILD ABUSE; AGED; ANXIETY; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LIFE CHANGE EVENTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 78650507190     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05398blu     Document Type: Article

References (49)

1. Antonijevic IA. Depressive disorders - is it time to endorse different pathophysiologies? Psychoneuroendocrinology. 2006;31(1):1-15.
2. Halbreich U. Major depression is not a diagnosis, it is a departure point to differential diagnosis - clinical and hormonal considerations [commentary and elaboration on Antonejevic's article]. Psychoneuroendocrinology. 2006;31(1):16-22; author reply, 23-24.
3. Joyce PR. Classification of mood disorders in DSM-V and DSM-VI. Aust N Z J Psychiatry. 2008;42(10):851-862.
4. Klein DN. Classification of depressive disorders in the DSM-V: proposal for a two-dimension system. J Abnorm Psychol. 2008;117(3):552-560.
5. van Praag HM. Kraepelin, biological psychiatry, and beyond. Eur Arch Psychiatry Clin Neurosci. 2008;258(suppl 2):29-32.
6. Thase ME. Recognition and diagnosis of atypical depression. J Clin Psychiatry. 2007;68(suppl 8):11-16.
7. West ED, Dally PJ. Effects of iproniazid in depressive syndromes. BMJ. 1959;1(5136):1491-1494.
8. Parker G, Roy K, Mitchell P, et al. Atypical depression: a reappraisal. Am J Psychiatry. 2002;159(9):1470-1479.
9. Angst J, Gamma A, Benazzi F, et al. Atypical depressive syndromes in varying definitions. Eur Arch Psychiatry Clin Neurosci. 2006;256(1):44-54.
10. Posternak MA, Zimmerman M. Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psychiatry. 2002;59(1):70-76.
11. Kendler KS, Eaves LJ, Walters EE, et al. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry. 1996;53(5):391-399.
12. Sullivan PF, Kessler RC, Kendler KS. Latent class analysis of lifetime depressive symptoms in the National Comorbidity Survey. Am J Psychiatry. 1998;155(10):1398-1406.
13. Sullivan PF, Prescott CA, Kendler KS. The subtypes of major depression in a twin registry. J Affect Disord. 2002;68(2-3):273-284.
14. Penninx BWJH, Beekman ATF, Smit JH, et al. NESDA Research Consortium. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res. 2008;17(3):121-140.
15. World Health Organization. Composite International Diagnostic Interview, Core Version 2.1: Interviewer's Manual. Sydney, Australia: World Health Organization; 1997.
16. Hagenaars JA, McCutcheon AL, eds. Applied Latent Class Analysis. Cambridge, United Kingdom: Cambridge University Press; 2002.
17. Rush AJ, Giles DE, Schlesser MA, et al. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res. 1986;18(1):65-87.
18. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477-486.
19. Fyer AJ, Weissman MM. Genetic linkage study of panic: clinical methodology and description of pedigrees. Am J Med Genet. 1999;88(2):173-181.
20. Lyketsos CG, Nestadt G, Cwi J, et al. The life-chart method to describe the course of psychopathology. Int J Methods Psychiatr Res. 1994;4:143-155.
21. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873-1875.
22. Costa PT Jr, McCrae RR. Domains and facets: hierarchical personality assessment using the revised NEO Personality Inventory. J Pers Assess. 1995;64(1):21-50.
23. Brugha T, Bebbington P, Tennant C, et al. The List of Threatening Experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med. 1985;15(1):189-194.
24. de Graaf R, Bijl RV, Smit F, et al. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry. 2002;159(4):620-629.
25. Chwastiak LA, Von Korff M. Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO DAS II) in a primary care setting. J Clin Epidemiol. 2003;56(6):507-514.
26. Craig CL, Marshall AL, Sjöström M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-1395.
27. Von Korff M. Epidemiologic and survey methods: chronic pain assessment. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. 2nd ed. New York, NY: Guilford Press; 2001:603-618.
28. McIntyre RS, Soczynska JK, Konarski JZ, et al. Should depressive syndromes be reclassified as "metabolic syndrome type II"? Ann Clin Psychiatry. 2007;19(4):257-264.
29. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54(3):216-226.
30. de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med. 2007;69(8):735-739.
31. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
32. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
33. Muthén LK, Muthén BO. Mplus User's Guide. 5th ed. Los Angeles, CA: Muthén & Muthén; 2007.
34. Nylund KL, Asparouhov T, Muthén B. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Modeling. 2008;14:535-569.
35. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
36. Lerman C, Caporaso N, Main D, et al. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol. 1998;17(1):56-62.
37. Harkness KL, Monroe SM. Childhood adversity and the endogenous versus nonendogenous distinction in women with major depression. Am J Psychiatry. 2002;159(3):387-393.
38. Parker G, Kiloh L, Hayward L. Parental representations of neurotic and endogenous depressives. J Affect Disord. 1987;13(1):75-82.
39. Parker G, Gladstone G, Wilhelm K, et al. Dysfunctional parenting: over-representation in non-melancholic depression and capacity of such specificity to refine sub-typing depression measures. Psychiatry Res. 1997;73(1-2):57-71.
40. Nemeroff CB. Neurobiological consequences of childhood trauma. J Clin Psychiatry. 2004;65(suppl 1):18-28.
41. Mezuk B, Eaton WW, Albrecht S, et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383-2390.
42. Mosovich SA, Boone RT, Reichenberg A, et al. New insights into the link between cardiovascular disease and depression. Int J Clin Pract. 2008;62(3):423-432.
43. Lu XY. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol. 2007;7(6):648-652.
44. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24-31.
45. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23(5):477-501.
46. Grigoriadis S, Robinson GE. Gender issues in depression. Ann Clin Psychiatry. 2007;19(4):247-255.
47. Halbreich U, Kahn LS. Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? J Affect Disord. 2007;102(1-3):245-258.
48. Angst J, Gamma A, Sellaro R, et al. Toward validation of atypical depression in the community: results of the Zurich Cohort Study. J Affect Disord. 2002;72(2):125-138.
49. Novick JS, Stewart JW, Wisniewski SR, et al. STAR*D investigators. Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry. 2005;66(8):1002-1011.